The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism-Reference-Cited by-同舟云学术

The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism

Published:2016-02-09 Issue:2 Volume:19 Page:191-196
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Shiota M,Fujimoto N,Yokomizo A,Takeuchi A,Kashiwagi E,Dejima T,Kiyoshima K,Inokuchi J,Tatsugami K,Eto M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/pcan20162.pdf

Reference31 articles.

1. Siegel RL, Miller KD, Jemal A . Cancer statistics, 2015. CA Cancer J Clin 2015; 62: 10–29.

2. Fujimoto H, Nakanishi H, Miki T, Kubota Y, Takahashi S, Suzuki K et al. Oncological outcomes of the prostate cancer patients registered in 2004: report from the Cancer Registration Committee of the JUA. Int J Urol 2011; 18: 876–881.

3. Morote J, Orsola A, Planas J, Trilla E, Raventós CX, Cecchini L et al. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy. J Urol 2007; 178: 1290–1295.

4. Perachino M, Cavalli V, Bravi F . Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance? BJU Int 2010; 105: 648–651.

5. Bertaglia V, Tucci M, Fiori C, Aroasio E, Poggio M, Buttigliero C et al. Effects of serum testosterone levels after 6 months of androgen deprivation therapy on the outcome of patients with prostate cancer. Clin Genitourin Cancer 2013; 11: 325–330.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex hormone-binding globulin and its critical role in prostate cancer: A comprehensive review;The Journal of Steroid Biochemistry and Molecular Biology;2025-01

2. Effect of metabolic syndrome on testosterone levels in patients with metastatic prostate cancer: a real-world retrospective study;PeerJ;2024-08-01

3. Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies;BJUI Compass;2024-01-10

4. Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review;Cancers;2023-07-03

5. Mass spectrometry redefines optimal testosterone thresholds in prostate cancer patients undergoing androgen deprivation therapy;The Prostate;2023-02-27